Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
FEDERATED HERMES, INC.
> RARE
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Ultragenyx Pharmaceutical Inc. | RARE | 1,776,600 | -749,000 | 81,954,558,000 | -19,322,002,000 | $46,130.00 |
03/31/2023 | Ultragenyx Pharmaceutical Inc. | RARE | 2,525,600 | -1,290,797 | 101,276,560,000 | 101,118,523,000 | $40,100.00 |
09/30/2022 | Ultragenyx Pharmaceutical Inc. | RARE | 3,816,397 | 19,308 | 158,037,000 | -68,498,000 | $41.41 |
06/30/2022 | Ultragenyx Pharmaceutical Inc. | RARE | 3,797,089 | -190,639 | 226,535,000 | -63,054,000 | $59.66 |
03/31/2022 | Ultragenyx Pharmaceutical Inc. | RARE | 3,987,728 | 858 | 289,589,000 | -45,667,000 | $72.62 |
12/31/2021 | Ultragenyx Pharmaceutical Inc. | RARE | 3,986,870 | -162 | 335,255,898 | -24,334,102 | $84.09 |
09/30/2021 | Ultragenyx Pharmaceutical Inc. | RARE | 3,987,032 | 135,722 | 359,590,000 | -7,633,000 | $90.19 |
06/30/2021 | Ultragenyx Pharmaceutical Inc. | RARE | 3,851,310 | -61,098 | 367,223,000 | -78,244,000 | $95.35 |
03/31/2021 | Ultragenyx Pharmaceutical Inc. | RARE | 3,912,408 | -368,120 | 445,467,000 | -147,087,000 | $113.86 |
12/31/2020 | Ultragenyx Pharmaceutical Inc. | RARE | 4,280,528 | 186,213 | 592,554,000 | 256,042,000 | $138.43 |
09/30/2020 | Ultragenyx Pharmaceutical Inc. | RARE | 4,094,315 | 13,956 | 336,512,000 | 17,346,000 | $82.19 |
06/30/2020 | Ultragenyx Pharmaceutical Inc. | RARE | 4,080,359 | 63,599 | 319,166,000 | 140,701,000 | $78.22 |
03/31/2020 | Ultragenyx Pharmaceutical Inc. | RARE | 4,016,760 | 1,044,752 | 178,465,000 | 51,530,000 | $44.43 |
12/31/2019 | Ultragenyx Pharmaceutical Inc. | RARE | 2,972,008 | 117,698 | 126,935,000 | 4,827,000 | $42.71 |
09/30/2019 | Ultragenyx Pharmaceutical Inc. | RARE | 2,854,310 | 1,079,658 | 122,108,000 | 9,418,000 | $42.78 |
06/30/2019 | Ultragenyx Pharmaceutical Inc. | RARE | 1,774,652 | 25,378 | 112,690,000 | -8,640,000 | $63.50 |
03/31/2019 | Ultragenyx Pharmaceutical Inc. | RARE | 1,749,274 | 471,955 | 121,330,000 | 65,792,000 | $69.36 |
12/31/2018 | Ultragenyx Pharmaceutical Inc. | RARE | 1,277,319 | -206,952 | 55,538,000 | -57,771,000 | $43.48 |
09/30/2018 | Ultragenyx Pharmaceutical Inc. | RARE | 1,484,271 | 66,720 | 113,309,000 | 4,342,000 | $76.34 |
06/30/2018 | Ultragenyx Pharmaceutical Inc. | RARE | 1,417,551 | 218,060 | 108,967,000 | 47,805,000 | $76.87 |
03/31/2018 | Ultragenyx Pharmaceutical Inc. | RARE | 1,199,491 | 98,691 | 61,162,000 | 10,107,000 | $50.99 |
12/31/2017 | Ultragenyx Pharmaceutical Inc. | RARE | 1,100,800 | 709,200 | 51,055,000 | 30,198,000 | $46.38 |
09/30/2017 | Ultragenyx Pharmaceutical Inc. | RARE | 391,600 | -25,500 | 20,857,000 | -5,049,000 | $53.26 |
06/30/2017 | Ultragenyx Pharmaceutical Inc. | RARE | 417,100 | 0 | 25,906,000 | -2,365,000 | $62.11 |
03/31/2017 | Ultragenyx Pharmaceutical Inc. | RARE | 417,100 | -21,200 | 28,271,000 | -2,546,000 | $67.78 |
12/31/2016 | Ultragenyx Pharmaceutical Inc. | RARE | 438,300 | -4,300 | 30,817,000 | -581,000 | $70.31 |
09/30/2016 | Ultragenyx Pharmaceutical Inc. | RARE | 442,600 | 442,600 | 31,398,000 | 31,398,000 | $70.94 |
06/30/2016 | Ultragenyx Pharmaceutical Inc. | RARE | 443,050 | 0 | 21,670,000 | -6,379,000 | $48.91 |
03/31/2016 | Ultragenyx Pharmaceutical Inc. | RARE | 443,050 | 43,250 | 28,049,000 | -16,801,000 | $63.31 |
12/31/2015 | Ultragenyx Pharmaceutical Inc. | RARE | 399,800 | 650 | 44,850,000 | 6,408,000 | $112.18 |
09/30/2015 | Ultragenyx Pharmaceutical Inc. | RARE | 399,150 | 550 | 38,442,000 | -2,371,000 | $96.31 |
06/30/2015 | Ultragenyx Pharmaceutical Inc. | RARE | 398,600 | 0 | 40,813,000 | 16,064,000 | $102.39 |
03/31/2015 | Ultragenyx Pharmaceutical Inc. | RARE | 398,600 | 109,700 | 24,749,000 | 12,072,000 | $62.09 |
12/31/2014 | Ultragenyx Pharmaceutical Inc. | RARE | 288,900 | 0 | 12,677,000 | -3,675,000 | $43.88 |
09/30/2014 | Ultragenyx Pharmaceutical Inc. | RARE | 288,900 | 150,000 | 16,352,000 | 10,117,000 | $56.60 |
<< Prev Next >> |
|